Header Logo

Connection

MARIA REDONDO to Adult

Back to Details
This is a "connection" page, showing publications MARIA REDONDO has written about Adult.
MARIA REDONDO
Connection Strength
0.832
Adult
  1. Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):e1046-e1050.
    View in: PubMed
    Score: 0.058
  2. Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes. Diabetologia. 2025 Mar; 68(3):588-601.
    View in: PubMed
    Score: 0.057
  3. Diabetes Study of Children of Diverse Ethnicity and Race: Study design. Diabetes Metab Res Rev. 2024 Mar; 40(3):e3744.
    View in: PubMed
    Score: 0.053
  4. Age Ain't Nothing But a Number . . . or Is It? Diabetes Care. 2023 06 01; 46(6):1135-1136.
    View in: PubMed
    Score: 0.051
  5. Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants. Diabetologia. 2023 01; 66(1):127-131.
    View in: PubMed
    Score: 0.049
  6. Index60 as an additional diagnostic criterion for type 1 diabetes. Diabetologia. 2021 04; 64(4):836-844.
    View in: PubMed
    Score: 0.044
  7. Sex differences in circulating leptin as a marker of adiposity in obese or overweight adolescents with type 1 diabetes. BMJ Open Diabetes Res Care. 2020 10; 8(1).
    View in: PubMed
    Score: 0.043
  8. GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.042
  9. Decline Pattern of Beta Cell Function in LADA: Relationship to GAD Autoantibodies. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.042
  10. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance. J Clin Endocrinol Metab. 2020 05 01; 105(5).
    View in: PubMed
    Score: 0.042
  11. Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2018 12; 41(12):2480-2486.
    View in: PubMed
    Score: 0.037
  12. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care. 2018 09; 41(9):1887-1894.
    View in: PubMed
    Score: 0.037
  13. TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care. 2018 02; 41(2):311-317.
    View in: PubMed
    Score: 0.035
  14. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med. 2008 Dec 25; 359(26):2849-50.
    View in: PubMed
    Score: 0.019
  15. Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes. J Clin Endocrinol Metab. 2006 May; 91(5):1705-13.
    View in: PubMed
    Score: 0.015
  16. A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts. Diabetes Technol Ther. 2025 Mar; 27(3):179-186.
    View in: PubMed
    Score: 0.014
  17. Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance. J Endocrinol Invest. 2025 Mar; 48(3):765-775.
    View in: PubMed
    Score: 0.014
  18. Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis. Diabetologia. 2024 Nov; 67(11):2507-2517.
    View in: PubMed
    Score: 0.014
  19. Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals. J Clin Endocrinol Metab. 2024 Jul 12; 109(8):2116-2123.
    View in: PubMed
    Score: 0.014
  20. Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes Care. 2024 Jun 01; 47(6):1048-1055.
    View in: PubMed
    Score: 0.014
  21. Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth. Diabetes Care. 2022 05 01; 45(5):1124-1131.
    View in: PubMed
    Score: 0.012
  22. Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts. Diabetes Care. 2021 10; 44(10):2329-2336.
    View in: PubMed
    Score: 0.011
  23. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001 Mar; 44(3):354-62.
    View in: PubMed
    Score: 0.011
  24. Diabetes Curriculum for Pediatric Endocrine Fellowship Utilizing Modified Team-Based Learning. MedEdPORTAL. 2020 08 13; 16:10948.
    View in: PubMed
    Score: 0.011
  25. Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals. Diabetes Obes Metab. 2020 06; 22(6):997-1000.
    View in: PubMed
    Score: 0.010
  26. Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents. Diabetes Care. 2020 03; 43(3):580-587.
    View in: PubMed
    Score: 0.010
  27. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ. 1999 Mar 13; 318(7185):698-702.
    View in: PubMed
    Score: 0.010
  28. Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk. Diabetologia. 2018 09; 61(9):2043-2053.
    View in: PubMed
    Score: 0.009
  29. Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid, Spain. Diabetes Metab. 1997 Dec; 23(6):519-23.
    View in: PubMed
    Score: 0.009
  30. The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults. J Clin Endocrinol Metab. 2017 12 01; 102(12):4596-4603.
    View in: PubMed
    Score: 0.009
  31. Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes? J Clin Endocrinol Metab. 2017 08 01; 102(8):2873-2880.
    View in: PubMed
    Score: 0.009
  32. Nonaqueous, Mini-Dose Glucagon for Treatment of Mild Hypoglycemia in Adults With Type 1 Diabetes: A Dose-Seeking Study. Diabetes Care. 2016 Mar; 39(3):465-8.
    View in: PubMed
    Score: 0.008
  33. The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol. 2013 Dec; 42(6):1772-90.
    View in: PubMed
    Score: 0.007
  34. Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2012 Dec; 96(6):1398-408.
    View in: PubMed
    Score: 0.006
  35. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest. 2001 Mar; 107(5):555-64.
    View in: PubMed
    Score: 0.003
  36. Dual-parameter model for prediction of type I diabetes mellitus. Proc Assoc Am Physicians. 1998 Mar-Apr; 110(2):126-35.
    View in: PubMed
    Score: 0.002
  37. Primary intrasellar germinoma with synchronous pineal tumor. Neuroradiology. 1997 Dec; 39(12):860-2.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.